Your browser doesn't support javascript.
loading
In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene.
De Giorgi, Marco; Park, So Hyun; Castoreno, Adam; Cao, Mingming; Hurley, Ayrea; Saxena, Lavanya; Chuecos, Marcel A; Walkey, Christopher J; Doerfler, Alexandria M; Furgurson, Mia N; Ljungberg, M Cecilia; Patel, Kalyani R; Hyde, Sarah; Chickering, Tyler; Lefebvre, Stephanie; Wassarman, Kelly; Miller, Patrick; Qin, June; Schlegel, Mark K; Zlatev, Ivan; Li, Rich Gang; Kim, Jong; Martin, James F; Bissig, Karl-Dimiter; Jadhav, Vasant; Bao, Gang; Lagor, William R.
Afiliação
  • De Giorgi M; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Park SH; Department of Bioengineering, Rice University, Houston, TX 77030, USA.
  • Castoreno A; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Cao M; Department of Bioengineering, Rice University, Houston, TX 77030, USA.
  • Hurley A; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Saxena L; Department of Bioengineering, Rice University, Houston, TX 77030, USA.
  • Chuecos MA; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Walkey CJ; Translational Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.
  • Doerfler AM; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Furgurson MN; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Ljungberg MC; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Patel KR; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Hyde S; Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA.
  • Chickering T; Department of Pathology, Texas Children's Hospital, Houston, TX 77030, USA.
  • Lefebvre S; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Wassarman K; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Miller P; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Qin J; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Schlegel MK; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Zlatev I; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Li RG; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Kim J; Alnylam Pharmaceuticals Inc, 675 W Kendall St, Cambridge, MA 02142, USA.
  • Martin JF; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Bissig KD; Texas Heart Institute, Houston, TX 77030, USA.
  • Jadhav V; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Bao G; Texas Heart Institute, Houston, TX 77030, USA.
  • Lagor WR; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
bioRxiv ; 2023 Jul 29.
Article em En | MEDLINE | ID: mdl-37546995
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article